TechFlow reports that on October 14, according to The Defiant, crypto asset manager 21Shares has listed its Anthropic synthetic Exchange-Traded Product (ETP, ticker CLAU) on the Vienna Multilateral Trading Facility (Vienna MTF), with the first trading day falling on October 13. The product is designed to provide investors with exposure to the market-implied valuation of artificial intelligence company Anthropic without requiring direct equity holdings.
The issuing entity for the product is 21Shares x FalconX Limited, with a first issuance of 5,000 certificates priced at $10 each. CLAU does not directly hold Anthropic equity but instead holds unlisted structured notes, with FalconX Sandpiper SPC acting as the counterparty. FalconX manages the underlying risk exposure through perpetual contracts traded on Binance and Hyperliquid, using Binance’s Anthropic perpetual contract and Kaiko reference rates as pricing benchmarks.
In terms of fees and structure, alongside a 1% annual product management fee, the product includes an underlying funding fee of up to 3% per annum, transaction costs, and perpetual funding rates. 21Shares has explicitly stated that the product does not confer shareholder rights; it will not convert into actual shares even if Anthropic completes an IPO in the future. The base prospectus further notes that the certificates are unsecured, meaning investors assume the credit risk of the issuer.





